Репозиторий Университета

Antihepatotoxic Activity of Liposomal Silibinin


  • Lutsenko S.
  • Gromovykh T.
  • Krasnyuk I.
  • Vasilenko I.
  • Feldman N.
Дата публикации:01.06.2018
Журнал: BioNanoScience
БД: Scopus
Ссылка: Scopus
Индекс цитирования: 2

Аннтотация

© 2018, Springer Science+Business Media, LLC, part of Springer Nature. The liposomal form of silibinin was obtained, and its antihepatotoxic activity in mice was studied using a model of acute toxic hepatitis caused by injection of carbon tetrachloride or paracetamol. It was shown that the use of the drug in therapy or prevention regimens leads to normalization of levels of transaminases and total protein in the blood of experimental animals. The results of the study showed that liposomal silibinin when administered intravenously shows a more pronounced hepatoprotective effect compared to intragastric administration of free silibinin. Thus, the effectiveness of the therapeutic action of silibinin can be significantly increased by using its liposomal form. Liposomal drug, in contrast to native silibinin, can be injected directly into the blood that significantly increases its bioavailability.


Вернуться назад